PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201528-09-2020
28-09-2020
LIC Housing invests in SPR City, Piramal Enterprises exits from project
The company's Director Chetan Bohra said that the capital raised would be utilised for advacing the construction and ensuring the completion of the residential project within this financial year25-09-2020
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201522-09-2020
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD
Intimation under Regulation 57 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')21-09-2020
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201518-09-2020
PIRAMAL ENTERPRISES LTD. - 500302 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201518-09-2020
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201516-09-2020
Blackstone, Partners Group in race to buy Piramal Glass
The investment firms have progressed to the final round of bidding for Piramal Glass Ltd.Piramal Enterprises has been raising funds through debt issues as well as weighing sales of some of its non-core units16-09-2020
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD
Intimation under Regulation 57 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201514-09-2020
CCI nod to Piramal Pharma's 20% stake sale deal with Carlyle group
Carlyle picked up a 20 per cent stake in Piramal Enterprises subsidiary Piramal Pharma for Rs 3,700 crore; it is one of the largest private equity deals in Indian pharmaceutical sector12-09-2020